Related Experiment Video

Updated: Oct 16, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

[The indices of intracardiac hemodynamics in patients with postinfarct cardiosclerosis]

S S Boev

    Likars'Ka Sprava
    |May 24, 2000
    PubMed

    Insights

    Postinfarction cardiosclerosis patients show reduced left ventricular pump function, especially those with decreased ejection fraction (EF). This decline indicates a need for inotropic medications to enhance myocardial function.

    Area of Science:

    • Cardiology
    • Cardiovascular Physiology

    Background:

    • Postinfarction cardiosclerosis can impair cardiac function.
    • Left ventricular ejection fraction (EF) is a key indicator of cardiac health.

    Purpose of the Study:

    • To investigate endocardiac hemodynamics in patients with postinfarction cardiosclerosis.
    • To correlate ejection fraction (EF) levels with left ventricular pump function.

    Main Methods:

    • Echocardiographic B- and M-mode techniques were employed.
    • Hemodynamics were assessed in 81 patients with varying ejection fractions (EF).

    Main Results:

    • Patients with postinfarction cardiosclerosis exhibited diminished left ventricular pump function.
    • A more pronounced decline in pump function was observed in patients with decreased ejection fraction (EF < 57%).

    Conclusions:

    • Reduced myocardial pump function in postinfarction cardiosclerosis, even without overt heart failure, warrants intervention.
    • Inotropic agents like cardiac glycosides and vasodilators are indicated to improve myocardial contractility.

    More Related Videos

    Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs08:19

    Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs

    Published on: July 12, 2022

    Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in G&#246;ttingen Minipigs and Landrace Pigs14:35

    Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

    Published on: April 17, 2021

    Related Concept Videos

    Acute Coronary Syndrome III: Diagnostic Studies01:30

    Acute Coronary Syndrome III: Diagnostic Studies

    Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
    Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

    Blood Studies for Cardiovascular System I: Cardiac Biomarkers

    Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
    The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
    Troponins
    Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...